Missing First Mammogram Increases Risk for Future Breast Cancer by More Than 50%, Study Finds
Missing a first screening mammogram was associated with a 53% greater risk of stage III breast cancer and a 40% higher risk of mortality from the disease.
Pooled Cohort Equations vs PREVENT: Statin Exposure Alters ASCVD Risk Predictions
The study found that although PREVENT-generated risk estimates were more consistent in a broad population, PCE estimates were more accurate in those taking statins.
Pilot Trial Challenges Routine Steroid Use After Pediatric Anaphylaxis ED Discharge
Corticosteroids following resolution of anaphylaxis should be chosen with clear, clinical rationale and reserved for select children, study authors concluded.
Elinzanetant Update: Phase 3 Findings Published in JAMA with PDUFA Date Set for October 26
If approved, the nonhormonal drug could offer an important new option for postmenopausal women seeking alternatives to hormone therapy.
FDA Updates Albuterol/Budesonide Label to Include Evidence of Exacerbation Risk Reduction in Mild Asthma
The updated prescribing information includes phase 3b BATURA trial results showing a 46% reduction in severe exacerbations in mild asthma vs albuterol.
Most Parents Trust Standard Childhood Vaccines, but Many Question Flu and COVID-19 Shots: KFF-Washington Post Survey
Most parents support childhood vaccines such as MMR and polio, but skepticism about seasonal and newer shots persists, along with distrust of federal agencies.
Real-World Data Support Effectiveness of Neffy (epinephrine nasal spray) for Acute Treatment of Anaphylaxis
A single dose of neffy was effective in nearly 90% of patients treated for anaphylactic reactions during oral food challenge and allergen immunotherapy.
Family Physician to Colleagues: Please, Value Your Own Mental Health
Teresa Lovins, MD, talked with Patient Care about suicidal ideation among patients and then focused on asking her colleagues to make their own mental health a priority.
A Family Physician on When to Manage Depression in Primary Care—and When to Refer
Family physician Teresa Lovins, MD, explains how primary care clinicians can determine when to manage depression and when urgent referral is needed.
How to Talk to Patients About Respiratory Virus Vaccines This Year? The Same Way We Always Do
William Schaffner, MD, advises first and foremost to stay away from politics, to acknowledge and normalize patient fear and concern, and to answer quickly and with confidence.
Back-to-School Pediatric Vaccination: A Family Physician’s Perspective on Boosting Rates, Countering Misinformation
Sarah Sams, MD, emphasizes education, empathy, and proactive communication to support families and protect public health.
Primary Care Needs the Right Tools to Identify MCI Early, Says Rodney Swenson, PhD
If primary care clinicians are to meet the cognitive screening demands that are growing with an aging population, they need the sharpest tools in the box, this expert says.
FDA Extends Review Period for Elinzanetant NDA for Menopausal Vasomotor Symptoms
Bayer's elinzanetant, a potential nonhormonal treatment for menopausal symptoms, awaits FDA approval after a 90-day review extension.
Novel GLP-1/GLP-2 Agent Reduces Body Weight by Up to 8.3% in Phase 1b Obesity Trial
ADA 2025: Dapiglutide showed promising safety and weight loss results in a phase 1b trial, targeting obesity and inflammation with once-weekly dosing.
ADA Standards of Care for Overweight and Obesity to Debut at 2025 Scientific Sessions
The ADA unveils the association's first Standards of Care for Overweight and Obesity, with a chapter on weight stigma and bias one of the first released.
2025 ACOG Annual Clinical & Scientific Meeting: What You May Have Missed
From primary care management of heavy menstrual bleeding to postpartum depression screening, find out what you may have missed at ACOG 2025.
Ruxolitinib Cream Demonstrates Long-Term Safety and Disease Control in Young Patients With Atopic Dermatitis
RAD 2025: In the TRuE-AD3 study, participants aged 2-6 and 7-11 years spent nearly half of the long-term treatment period free of medication.
INTEGUMENT-OLE: Roflumilast Cream Maintains Long-Term Disease Control in Pediatric and Adolescent Atopic Dermatitis
RAD 2025: Roflumilast cream significantly improved atopic dermatitis in children and adolescents through 52 weeks, offering a safe, effective treatment option.
Women’s Health Takeaways for Primary Care: Expert Insights From ACOG 2025
Hear experts' takeaways from ACOG 2025 on menopause care, postpartum depression screening, and obesity management.
From HPV to GLP-1 RA: Primary Care Quiz on Recent Women’s Health & Endocrine Evidence
From HPV vaccination to PCOS management, this quiz is designed for primary care providers who want to stay ahead in women's health.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Back-to-School Pediatric Vaccination: A Family Physician’s Perspective on Boosting Rates, Countering Misinformation")
